Tata Sons pays Rs 4,475 crore in annual dividends; hypothetical investment could generate Rs 82,000 crore for philanthropy, says Harsh Goenka

RPG Enterprises Chairman Harsh Goenka has shared a hypothetical scenario in which Tata Sons could generate up to Rs 82,000 crore in annual income for philanthropy and social good by selling its listed equity portfolio and investing the proceeds in safe instruments.

In a post on X, Goenka pointed out that Tata Sons pays around Rs 4,475 crore in annual dividends. He then outlined a thought experiment involving the company's listed equity portfolio, which he valued at Rs 11.68 lakh crore.

Goenka suggested that if the entire portfolio were sold and the proceeds invested in instruments yielding 6-7% annually, the investment could generate income of around Rs 70,000-82,000 crore a year. He said this income could potentially be made available entirely for philanthropy and social good.


At a 6% annual yield, an investment of Rs 11.68 lakh crore would generate approximately Rs 70,080 crore. At a 7% yield, the annual income would amount to around Rs 81,760 crore, taking the potential figure close to Rs 82,000 crore.

The calculation compares the annual dividend figure of Rs 4,475 crore cited by Goenka with the potential income from investing the proceeds of a hypothetical sale of the listed equity portfolio in instruments offering the assumed returns.

"Tata Sons pays a dividend of around Rs 4,475 crore a year. Suppose its Rs 11.68 lakh crore listed equity portfolio were sold and invested in safe instruments yielding 6-7%, it could generate an annual income of Rs 70,000-82,000 cr, potentially all available for philanthropy and social good," said Goenka.

Goenka, however, made it clear that he was not recommending such a move. "I am certainly not suggesting this. Just a hypothetical thought worth pondering," he wrote in his post.

His remarks were presented as a thought experiment exploring how the proceeds from Tata Sons' listed equity portfolio could potentially generate income for philanthropic purposes, rather than as a proposal to sell the investments.

Disclosure: This article has been written by Kumar Gaurav, who is not a Sebi-registered Research Analyst or an Investment Adviser. Gaurav and their ‘relative(s)’ (as defined under Section 2(77) of the Companies Act, 2013) do not hold any financial interest in the companies mentioned in this article as of the date of publication. The views/recommendations mentioned in this article, wherever applicable, are those of the respective Sebi-registered Research Analyst/brokerage and have been reproduced/reported with due attribution. They should not be construed as the views or recommendations of The Economic Times Digital or the journalist. Readers are advised to consider the original research report and make their investment decisions based on their own assessment. Brokerage disclaimers here